You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Preclinical Trial of Therapeutic Angiogenesis Plus Angioplasty and Stenting for Renal Vascular Disease
SBC: LEFLORE TECHNOLOGIES LLC Topic: 400Abstract Chronic kidney disease CKD is a progressive disorder affecting almost of the general population and this disease has shown a relentless growth over the past decades Patients with CKD have higher rates of hospitalization greater mortality shorter life expectancy and their healthcare costs are up to times more expensive than non CKD patients Thus treatments to slow halt ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury
SBC: PROTHERA BIOLOGICS, INC. Topic: 105Neonatal hypoxia ischemiaHIremains a major cause of acute perinatal brain injuryleading ultimately to neurologic dysfunction manifesting as cerebral palsymental retardationand epilepsyUnfortunatelycurrent treatment and prevention strategies in newborns are limitedThere are no currently available therapies to prevent treat and or attenuate brain damage in premature infants other than supportive car ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Evidence-Based Pain Intervention for Veterans: Leveraging Mobile and Social Media
SBC: Pro-Change Behavior Systems, Inc. Topic: NCCIHChronic musculoskeletal pain creates a significant public health burden, and Veterans are disproportionately affected. The frequency and extent of co-occurrence of pain and PTSD, pain and Traumatic Brain Injury (TBI), all three conditions (Post-deployment Multi-symptom Disorder (PMD), and other multi-symptom syndromes can complicate and reduce the effectiveness of pain treatment. Furthermore, the ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Novel Antigen-Specific Immunomodulatory Tregitope-based Therapy to Address Autoimmune Pathogenesis in Graves' Disease
SBC: EPIVAX, INC. Topic: 200ABSTRACT SignificanceGravesdiseaseGDone of the most prevalent autoimmune diseasesis caused by stimulating autoantibodiesTSAbto the Thyroid Stimulating Hormone ReceptorTSHRresulting in hyperthyroidismCurrent methods for managing hyperthyroidism in GD target excess thyroid hormone secretion by ablation or removal of the thyroid or by blocking thyroid hormone synthesisEach of these therapies is assoc ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
GeoMetrix: Rapid, Reliable, and Global Analytics using Commercial Satellite Imagery
SBC: VISION SYSTEMS INC Topic: SB162009The pace of warfare is increasing rapidly with the emergence of numerous asymmetrical threats exhibiting complex interdependencies and shifting alliances. Never has it been more essential to acquire detailed tactical intelligence in time scales in hours ...
SBIR Phase II 2017 Department of DefenseDefense Advanced Research Projects Agency -
Calcaftor, a CFTR stabilizer for Cystic Fibrosis treatment
SBC: CALISTA THERAPEUTICS INC Topic: NIDDKDESCRIPTION (provided by applicant): Calista Therapeutics has invented Calcaftor, a first-in-class peptide drug that can treat all Cystic Fibrosis (CF) patients. Calcaftor is validated in the gold standard pre-clinical model of CF using F508 -CFTR lung tissue harvested from CF transplant patients. Results from this model demonstrated a gt25 hour duration of action that enables once daily inhaled n ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Inter-alpha-inhibitors in Hypoxic-Ischemic Brain Injury
SBC: PROTHERA BIOLOGICS, INC. Topic: NINDSDESCRIPTION (provided by applicant): Neonatal hypoxia-ischemia (HI) remains a major cause of acute perinatal brain injury, leading ultimately to neurologic dysfunction manifesting as cerebral palsy, mental retardation, and epilepsy. Cerebral oxygen deprivation and/or reduced blood flow due to umbilical cord occlusion, prolonged labor, and/or intracranial hemorrhage produce an inflammatory respons ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
IGF::OT::IGF High-Impact Substance Abuse Prevention Technologies. SBIR Phase I. Period of Performance 7/16/2014-1/15/2015
SBC: Pro-Change Behavior Systems, Inc. Topic: NIDAThe overarching objective of this project is to develop an innovative technological tool that will facilitate the implementation of an evidence-based substance abuse prevention program and related health behavior risk programs among military personnel. PUBLIC HEALTH RELEVANCE
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Open System Manufacturing of Large Sensing/Weapons Platforms
SBC: Applied Radar, Inc. Topic: SB102005In order to maintain our nation’s technological superiority on air, sea and land, we must respond quicker to emerging threats and reduce the cost of major sensing platforms. Every DoD platform developed nowadays contains at least one sensor, whether it be RF, EO/IR, or acoustic. In fact, in a lot of recent developments, the platform is built around the sensor and exists only to support the senso ...
SBIR Phase I 2010 Department of DefenseDefense Advanced Research Projects Agency -
Innovative Approaches to Low Power, Sub-Threshold Electronic Circuits
SBC: CAMGIAN MICROSYSTEMS CORP Topic: SB082045This program proposes to demonstrate an ultra-low power design methodology and circuits for digital logic employing advanced dynamic voltage scaling (DVS) for asynchronous NULL Convention Logic (NCL) circuits operating in sub-threshold to super-threshold voltage regimes. The power supply voltages of logic block partitions will be independently set by on-chip voltage controllers based on the data p ...
SBIR Phase II 2010 Department of DefenseDefense Advanced Research Projects Agency